UBS Maintains Buy on Alvotech, Lowers Price Target to $6
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $10 to $6.
UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $10 to $6.